A Clinical Study on TILs for the Treatment of Advanced Solid Tumors

Summary

This study is an open exploratory clinical study to evaluate the safety, tolerance, immune response, and initial efficacy of autologous tumor infiltrating lymphocyte LM103 injection in advanced solid tumor patients . The research treatment includes fludarabine and cyclophosphamide, autologous tumor infiltrating lymphocytes (TILs) infusion, and Interleukin-2 therapy.

Timeline

Start

2023-08

Primary completion

2026-04

Completion

2026-08

Drugs

Indications